BiotechTubeBiotechTube
Home/Pipeline/Kikyou Extract

Kikyou Extract

Atopic Dermatitis

Phase 3Under development (in China)

Key Facts

Indication
Atopic Dermatitis
Phase
Phase 3
Status
Under development (in China)
Company
Zeria Pharmaceutical

About Zeria Pharmaceutical

Zeria Pharmaceutical is a mid-sized, established Japanese pharmaceutical company with a history spanning over 70 years. It has built a stable business foundation through a multi-pronged strategy involving in-house development, strategic licensing, and marketing of both prescription and consumer health products. The company's strategic direction focuses on strengthening its core gastroenterology franchise while expanding into new therapeutic areas like dermatology and pursuing growth in Asian markets.

View full company profile

Therapeutic Areas

GastroenterologyDermatologyMetabolic DisordersConsumer Health

Other Atopic Dermatitis Drugs

DrugCompanyPhase
LebrikizumabEli LillyPhase 3
DupixentSanofiCommercial
ASP2408Astellas PharmaPhase 2
KW-6356Kyowa KirinPhase 2
KHK4083Kyowa KirinPhase 2
Opzelura (ruxolitinib cream)Ono PharmaceuticalApproved
ONO-7913Ono PharmaceuticalPhase 2
KT-474Kymera TherapeuticsPhase 2
GRC 27864Glenmark PharmaceuticalsPhase 2
ARQ-234Arcutis BiotherapeuticsPreclinical/Phase 1
STAR-0310BioCryst PharmaceuticalsPhase 1
RezpegaldesleukinNektar TherapeuticsPhase 2b